RTN4R and neoplasm: In particular, NGR and Cysteine-asparagine–glycine–arginine-cysteine (CNGRC), which was derived from NGR peptide, have been proven to be useful for delivering cytotoxic drugs, proapoptotic peptides, and tumor necrosis factor-α (TNF) to tumor vasculature.